Effect of new thromboxane A2 synthesis inhibitor tetramethyl-pyrazine on pancreatic transplantation in diabetic rats.
Chen
S
S
Institute of Organ Transplantation, Tongji Medical University, Wuhan, China.
Yan
Y H
YH
Wang
Y
Y
Li
J W
JW
Ma
S X
SX
D000419:Albuminuria; D000818:Animals; D001572:Benzofurans / Q000494:pharmacology; D016572:Cyclosporine / Q000494:pharmacology; D003921:Diabetes Mellitus, Experimental / Q000097:blood / Q000601:surgery* / Q000652:urine; D003928:Diabetic Nephropathies / Q000503:physiopathology*; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D007166:Immunosuppressive Agents / Q000494:pharmacology; D007668:Kidney / Q000503:physiopathology; D009929:Organ Size; D016035:Pancreas Transplantation / Q000276:immunology / Q000502:physiology*; D011719:Pyrazines / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D013928:Thromboxane A2 / Q000096:biosynthesis; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors*; D014185:Transplantation, Isogeneic; D001613:beta 2-Microglobulin / Q000652:urine
D001572:Benzofurans; D004791:Enzyme Inhibitors; D007166:Immunosuppressive Agents; D011719:Pyrazines; D001613:beta 2-Microglobulin; D013928:Thromboxane A2; D016572:Cyclosporine; D013930:Thromboxane-A Synthase; C039936:furegrelate; C017953:tetramethylpyrazine